Mylan has been named manufacturer of the year by pharmaceutical services company AmerisourceBergen Corporation.

The US-based company won the award for generic pharmaceutical companies with sales of more than $50 million.

The news comes just days after the company announced it had posted a second-quarter net loss of $8.37 million, or $0.03 per share, though revenues had more than doubled after the company acquired Merck KGaA’s generics business in October last year.

AmerisourceBergen said it had selected Mylan as the winner for its “responsiveness, collaboration and investment in strategic initiatives”.

"Being named Manufacturer of the Year by AmerisourceBergen reflects Mylan's historical commitment to and close working relationship with our business partners," Mylan North America President Hal Korman said.

"We recognize that strong partner relationships are built on mutually supportive initiatives and close collaboration. The synergies derived by combining our respective strengths clearly enhance our customers' satisfaction and, ultimately, generate value for our shareholders."